X
Details:
AGN-151586 (trenibotulinumtoxinE) is a first-in-class, short-acting neurotoxin, which is investigated for the treatment of Glabellar Lines. If approved, BoNT/E will be the first neurotoxin of its kind available to patients.
Lead Product(s): TrenibotulinumtoxinE
Therapeutic Area: Dermatology Product Name: AGN-151586
Highest Development Status: Phase IIIProduct Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 24, 2023
Iran Expo
Not Confirmed
Contact SupplierDetails:
Botox Cosmetic (onabotulinumtoxinA) is first and only product of its kind that is approved by U.S. FDA to treat three areas, temporarily improving the appearance of moderate to severe forehead lines, glabellar lines and crow's feet in adults.
Lead Product(s): OnabotulinumtoxinA
Therapeutic Area: Dermatology Product Name: Botox Cosmetic
Highest Development Status: Phase IIIProduct Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable September 18, 2023
Iran Expo
Not Confirmed
Contact SupplierDetails:
Juvederm Voluma™ XC (hyaluronic acid) is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face in adults over the age of 21.
Lead Product(s): Hyaluronic Acid
Therapeutic Area: Dermatology Product Name: Juvederm Volux XC
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 18, 2023
Iran Expo
Not Confirmed
Contact SupplierDetails:
The SkinMedica (coffea arabica) Even & Correct products are hydroquinone-free, well tolerated, and effective on all skin types and for multiple ethnicities. Most SkinMedica® products are intended to meet the FDA's definition of a cosmetic product.
Lead Product(s): Coffea Arabica,Caffeine,Hydrolyzed Rice Protein
Therapeutic Area: Dermatology Product Name: SkinMedica
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 17, 2023
Iran Expo
Not Confirmed
Contact SupplierDetails:
BOTOX (OnabotulinumtoxinA) Cosmetic is a prescription medicine that is injected into muscles and used to temporarily improve the look of moderate to severe forehead lines, crow's feet lines, and frown lines between the eyebrows in adults.
Lead Product(s): OnabotulinumtoxinA
Therapeutic Area: Dermatology Product Name: Botox
Highest Development Status: ApprovedProduct Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable November 02, 2022
Iran Expo
Not Confirmed
Contact SupplierDetails:
BOTOX® Cosmetic (onabotulinumtoxinA) is first and only product of its kind that is approved by U.S. FDA to treat three areas, temporarily improving the appearance of moderate to severe forehead lines, glabellar lines and crow's feet in adults.
Lead Product(s): OnabotulinumtoxinA
Therapeutic Area: Dermatology Product Name: Botox
Highest Development Status: ApprovedProduct Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable September 13, 2022
Iran Expo
Not Confirmed
Contact SupplierDetails:
Data analyses of onabotulinumtoxinA (BOTOX®) in adult patients with chronic migraine, cervical dystonia, overactive bladder, spasticity, and pediatric patients with neurogenic detrusor overactivity provide further insights on real-world utilization and long-term use.
Lead Product(s): OnabotulinumtoxinA
Therapeutic Area: Neurology Product Name: Botox
Highest Development Status: ApprovedProduct Type: Large molecule
Recipient: AbbVie Inc
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable July 25, 2022
Iran Expo
Not Confirmed
Contact SupplierDetails:
VUITY, an optimized formulation of pilocarpine, established eye care therapeutic, specifically designed to treat age-related blurry near vision. It is delivered with proprietary pHast™ technology, which allows VUITY to rapidly adjust to physiologic pH of the tear film.
Lead Product(s): Pilocarpine Hydrochloride
Therapeutic Area: Ophthalmology Product Name: Vuity
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 28, 2022
Iran Expo
Not Confirmed
Contact SupplierDetails:
VUITY is an optimized formulation of pilocarpine, an established eye care therapeutic, specifically designed to treat age-related blurry near vision. It is delivered with proprietary pHas technology, which allows VUITY to rapidly adjust to physiologic pH of the tear film.
Lead Product(s): Pilocarpine Hydrochloride
Therapeutic Area: Ophthalmology Product Name: Vuity
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 19, 2022
Iran Expo
Not Confirmed
Contact SupplierDetails:
BOTOX Cosmetic (onabotulinumtoxinA), the first and only neurotoxin product approved by U.S.FDA, to temporarily improve the look of moderate to severe lines in three areas; frown lines, crow's feet and forehead lines.
Lead Product(s): OnabotulinumtoxinA
Therapeutic Area: Dermatology Product Name: Botox
Highest Development Status: ApprovedProduct Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 13, 2022
Iran Expo
Not Confirmed
Contact Supplier
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
